Iksuda Therapeutics raises $47m to progress ADC pipeline
Iksuda will use the funds to support the progression of IKS03 into first-in-human Phase I clinical trials
Read More
Tag: B-cell cancers
- Transgene completes randomisation in phase 2 trial of tg4050
- Bayer wins MHRA approval for Kerendia in heart failure
- Oxford BioTherapeutics signs collaboration with Bristol Myers Squibb
- Kainova expands DT 7012 trial into Europe
- Amgen reports positive phase 3 results for subcutaneous TEPEZZA in thyroid eye disease
